Form 4: BioAtla's Chief Medical Officer, Eric Sievers, Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Eric Sievers, Chief Medical Officer of BioAtla, Inc., reports a transaction involving the withholding of shares by the issuer to cover income tax obligations related to vesting restricted stock units.
Summary
- On August 31, 2024, BioAtla, Inc. withheld 572 shares of common stock from Eric Sievers, the Chief Medical Officer, to satisfy income tax obligations.
- The shares were withheld at a price of $1.77 per share.
- Following the transaction, Sievers directly owns 207,562 shares of BioAtla common stock.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing regarding stock transactions for tax purposes, indicating a neutral sentiment.
Industry Context
This filing is a routine disclosure related to executive compensation and tax obligations, common in publicly traded companies.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a routine tax-related stock withholding.
Key Dates
| Date | Description |
|---|---|
| 08/31/2024 | Date of transaction where shares were withheld to cover tax obligations. |
| 09/03/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.